Publications

1. Gatidis S, Ponisio MR, Borgwardt L, Cain T, Fran P, HAmdi M, Johnson GB et al. Pediatric PET/MRI: The How and Why RadioGraphics. 2024.
   
2. Ahmed M, Kwon E, Johnson GB. Survival Patterns Based on First-site-Specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same? European Urology Open Science. 2024.
   
3. Muniz M, Loprinzi CL, Orme JJ, Koch RM, Mahmoud AM, Kase AM, Riaz IB, Andrews JR, Thorpe MP, Johnson GB, Kendi AT, Kwon ED, Nauseef JT, Morgans AK, Sartor O, Childs DS. Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going. Cancer Treat Rev. 2024 Jun; 127:102748 Epub 2024 Apr 30
   View PubMed
4. Muniz M, Childs DS, Orme JJ, Johnson GB, Sartor O. Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy. Clin Nucl Med. 2024 Apr 01; 49(4):e164-e165. Epub 2024 Feb 06.
   View PubMed
5. Mahmoud AM, Ahmed ME, Kendi AT, Thorpe M, Johnson GB, Riaz IB, Orme JJ, Kwon ED, Andrews JR, Childs DS. Low PSA radiographic disease progression on C11-choline PET. BJUI Compass. 2024 Mar; 5 (2):319-324 Epub 2023 Oct 25
   View PubMed
6. Mahmoud AM, Childs DS, Ahmed ME, Tuba Kendi A, Johnson GB, Orme JJ, Stish BJ, Phillips RM, Park SS, Davis BJ, Andrews JR, Kwon ED. Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis. Prostate. 2024 Feb; 84 (3):237-244 Epub 2023 Oct 29
   View PubMed
7. McKone EL, Sutton EA, Johnson GB, Phillips RM. Application of Advanced Imaging to Prostate Cancer Diagnosis and Management: A Narrative Review of Current Practice and Unanswered Questions. J Clin Med. 2024 Jan 13; 13 (2)
   View PubMed
8. Di Carli MF, Gormsen LC, Chareonthaitawee P, Johnson GB, Beanlands R, DeKemp R, Schindler T, Gropler R, Kulkarni H, McNeely P, Soman P, Oz O, Zaha V, Sorensen J, Harms H, Orlandi C, Vandenbroucke E, Udelson J. Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW. J Nucl Cardiol. 2024 Jan; 31:101779 Epub 2023 Dec 05
   View PubMed
9. Belge Bilgin G, Bilgin C, Burkett BJ, Orme JJ, Childs DS, Thorpe MP, Halfdanarson TR, Johnson GB, Kendi AT, Sartor O. Theranostics and artificial intelligence: new frontiers in personalized medicine. Theranostics. 2024; 14 (6):2367-2378 Epub 2024 Mar 25
   View PubMed
10. Martin MD, Henry TS, Berry MF, Johnson GB, Kelly AM, Ko JP, Kuzniewski CT, Lee E, Maldonado F, Morris MF, Munden RF, Raptis CA, Shim K, Sirajuddin A, Small W Jr, Tong BC, Wu CC, Donnelly EF, Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria(R) Incidentally Detected Indeterminate Pulmonary Nodule. J Am Coll Radiol. 2023 Nov; 20 (11S):S455-S470
    View PubMed
11. Prichard DO, O'Connor MK, Johnson GB, Wang XJ. Metastasis-directed therapy for metachronous lung metastases in prostate cancer JU Open Plus. 2023.
    
12. Veit-Haibach P, Ahlstrom H, Boellaard R, Delgado Bolton RC, Hesse S, Hope T, Huellner MW, Iagaru A, Johnson GB, Kjaer A, Law I, Metser U, Quick HH, Sattler B, Umutlu L, Zaharchuk G, Herrmann K. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology. Eur J Nucl Med Mol Imaging. 2023 Oct; 50 (12):3513-3537 Epub 2023 Aug 25
    View PubMed
13. Jang A, Kendi AT, Johnson GB, Halfdanarson TR, Sartor O. Targeted Alpha-Particle Therapy: A Review of Current Trials. Int J Mol Sci. 2023 Jul 19; 24(14).
    View PubMed
14. Burkett BJ, Bartlett DJ, McGarrah PW, Lewis AR, Johnson DR, Berberoglu K, Pandey MK, Packard AT, Halfdanarson TR, Hruska CB, Johnson GB, Kendi AT. A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements. Radiol Imaging Cancer. 2023 Jul; 5 (4):e220157
    View PubMed
15. Gococo-Benore DA, Kuhlman J, Parent EE, Sharma A, Accurso J, Yang M, Kendi AT, Johnson G, Sonbol MB, Hobday T, Halfdanarson TR, Starr J. Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden. J Nucl Med. 2023 Jun; 64 (6):880-884 Epub 2023 Apr 20
    View PubMed
16. Badawy M, Johnson G, Wee C, Halfdanarson TR, Abdelrazek A, Packard A, Jain M, Thorpe M, Kendi. Intestinal obstruction in patients receiving peptide receptor radionuclide therapy for gastroenteropancreatic neuroendocrine tumors: potential predictors and association with overall survival. J Nucl Med. 2023; 64(Supplement 1):439.
    
17. Quinn E, Olson C, Jain MK, Sullivan J, Thorpe MP, Johnson GB, Young JR. Technologist-Based Implementation of Total Metabolic Tumor Volume into Clinical Practice. J Nucl Med Technol. 2023 Mar; 51 (1):57-59 Epub 2022 Nov 09
    View PubMed
18. Ahmed ME, Andrews JR, Mahmoud AM, Lee MS, Childs DS, Kendi AT, Johnson GB, Tollefson MK, Boorjian SA, Karnes RJ, Kwon ED. Survival patterns based on site-specific visceral metastasis in metastatic prostate cancer patients: Are outcomes of visceral metastases the same? ASCO. 2023.
    
19. Young JR, Mugu VK, Johnson GB, Ehman EC, Packard AT, Homb AC, Nathan MA, Thanarajasingam G, Kemp BJ. Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma. Medicine (Baltimore). 2023 Feb 10; 102 (6):e32665
    View PubMed
20. Saha S, Vierkant RA, Johnson GB, Parvinian A, Wermers RA, Foster T, McKenzie T, Dy B, Lyden M. C(11) choline PET/CT succeeds when conventional imaging for primary hyperparathyroidism fails. Surgery. 2023 Jan; 173 (1):117-123 Epub 2022 Oct 11
    View PubMed
21. Rajamohan N, Khasawneh H, Singh A, Suman G, Johnson GB, Majumder S, Halfdanarson TR, Goenka AH. PET/CT and PET/MRI in neuroendocrine neoplasms. Abdom Radiol (NY). 2022 Dec; 47 (12):4058-4072 Epub 2022 Apr 15
    View PubMed
22. Lucien F, Kim Y, Qian J, Orme JJ, Zhang H, Arafa A, Abraha F, Thapa I, Tryggestad EJ, Harmsen WS, Kosti J, Ali H, Lowe VJ, Johnson GB, Kwon ED, Dong H, Park SS. Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity. Int J Radiat Oncol Biol Phys. 2022 Nov 15; 114 (4):725-737 Epub 2022 June 04
    View PubMed
23. Badawy M, Johnson G, Jain M, Kendi AT, Johnson DR, Porter A, Yang M, Sonbol MB. Intracranial neuroendocrine tumour simulating meningioma for several years: an overview of diagnosis and treatment. BJR Case Rep. 2022 Sep; 8(3):20210222. Epub 2022 Jan 27.
    View PubMed
24. Thompson SM, Suman G, Torbenson MS, Chen ZE, Jondal DE, Patra A, Ehman EC, Andrews JC, Fleming CJ, Welch BT, Kurup AN, Roberts LR, Watt KD, Truty MJ, Cleary SP, Smoot RL, Heimbach JK, Tran NH, Mahipal A, Yin J, Zemla T, Wang C, Fogarty Z, Jacobson M, Kemp BJ, Venkatesh SK, Johnson GB, Woodrum DA, Goenka AH. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and (68) Ga-PSMA-11 PET Using Cyclotron-Produced (68) Ga. Hepatol Commun. 2022 May; 6 (5):1172-1185 Epub 2021 Nov 15
    View PubMed
25. Reisenauer JS, Eiken PW, Callstrom MR, Johnson GB, Pierson K, Lechtenberg B, Blackmon SH. A prospective trial of CT-guided percutaneous microwave ablation for lung tumors. J Thorac Dis. 2022 Apr; 14 (4):939-951
    View PubMed
26. Roden AC, Rakshit S, Johnson GB, Jenkins SM, Mansfield AS. Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial Tumors. Front Oncol. 2022; 12:823667 Epub 2022 Feb 07
    View PubMed
27. Patra A, Khasawneh H, Suman G, Nathan MA, Packard AT, Johnson GB, Goenka AH. Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer: (11)C-Choline PET/CT With Multimodality Correlation. AJR Am J Roentgenol. 2022 Jan; 218 (1):141-150 Epub 2021 Aug 04
    View PubMed
28. Zhang H, Orme JJ, Abraha F, Stish BJ, Lowe VJ, Lucien F, Tryggestad EJ, Bold MS, Pagliaro LC, Choo CR, Brinkmann DH, Iott MJ, Davis BJ, Quevedo JF, Harmsen WS, Costello BA, Johnson GB, Nathan MA, Olivier KR, Pisansky TM, Kwon ED, Dong H, Park SS. Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in (11)C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2021 Dec 1; 27 (23):6376-6383 Epub 2021 Sept 30
    View PubMed
29. Hope TA, Graves CE, Calais J, Ehman EC, Johnson GB, Thompson D, Aslam M, Duh QY, Gosnell JE, Shen WT, Roman SA, Sosa JA, Kluijfhout WP, Seib CD, Villaneuva-Meyer JE, Pampaloni MH, Suh I. Accuracy of (18)F-Fluorocholine PET for the Detection of Parathyroid Adenomas: Prospective Single-Center Study. J Nucl Med. 2021 Nov; 62 (11):1511-1516 Epub 2021 Mar 05
    View PubMed
30. AbouEzzeddine OF, Davies DR, Scott CG, Fayyaz AU, Askew JW, McKie PM, Noseworthy PA, Johnson GB, Dunlay SM, Borlaug BA, Chareonthaitawee P, Roger VL, Dispenzieri A, Grogan M, Redfield MM. Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2021 Nov 1; 6 (11):1267-1274
    View PubMed
31. Sandhya Manohar, Panagiotis Kompotiatis, Thorvardur R Halfdanarson, Timothy J Hobday, Matthew Thorpe, Geoffrey B Johnson, Ayse Tuba Kendi, Nelson Leung.. 177Lu-dotatate use in chronic kidney disease patients: A single center experience Journal of Onco-Nephrology. 2021; 5(3):162-171.
    
32. Schroeder DG, Jang S, Johnson DR, Takahashi H, Navin PJ, Broski SM, Thorpe MP, Johnson GB, Young JR. Frequency and Characteristics of Nodal and Deltoid FDG and (11)C-Choline Uptake on PET Performed After COVID-19 Vaccination. AJR Am J Roentgenol. 2021 Nov; 217 (5):1206-1216 Epub 2021 May 19
    View PubMed
33. Panda A, Garg I, Truty MJ, Kline TL, Johnson MP, Ehman EC, Suman G, Anaam DA, Kemp BJ, Johnson GB, Halfdanarson TR, Venkatesh SK, Fidler JL, Goenka AH. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival. AJR Am J Roentgenol. 2021 Sep; 217(3):730-740. Epub 2020 Oct 21.
    View PubMed
34. Kohlenberg JD, Panda A, Johnson GB, Castro MR. Radiologic and clinicopathologic characteristics of thyroid nodules with focal 68Ga-DOTATATE PET activity. Nucl Med Commun. 2021 May 1; 42 (5):510-516
    View PubMed
35. Dewey BJ, Howe BM, Spinner RJ, Johnson GB, Nathan MA, Wenger DE, Broski SM. FDG PET/CT and MRI Features of Pathologically Proven Schwannomas. Clin Nucl Med. 2021 Apr 1; 46 (4):289-296
    View PubMed
36. Durski JM, Hruska CB, Bogsrud TV, Ryder M, Johnson GB. 123I Scan With Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry Before 131I Treatment of Metastatic Thyroid Cancer. Clin Nucl Med. 2021 Mar 1; 46 (3):e151-e153
    View PubMed
37. Burkett BJ, Dundar A, Young JR, Packard AT, Johnson GB, Halfdanarson TR, Eiring RA, Gansen DN, Patton CM, Kendi AT. How We Do It: A Multidisciplinary Approach to (177)Lu DOTATATE Peptide Receptor Radionuclide Therapy. Radiology. 2021 Feb; 298 (2):261-274 Epub 2020 Nov 24
    View PubMed
38. Panda A, Wiseman GA, Koster MJ, Warrington KJ, Johnson GB. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography of giant cell arteritis with lower extremity involvement in association with polymyalgia rheumatica. World J Nucl Med. 2021 Jan-Mar; 20 (1):90-92 Epub 2020 Oct 02
    View PubMed
39. Shouman K, Broski SM, Muchtar E, Pendleton CA, Johnson GB, Tracy J, Engelstad JK, Spinner RJ, Dyck PJB. Novel imaging techniques using (18) F-florbetapir PET/MRI can guide fascicular nerve biopsy in amyloid multiple mononeuropathy. Muscle Nerve. 2021 Jan; 63 (1):104-108 Epub 2020 Nov 04
    View PubMed
40. Rowe SP, Johnson GB, Pomper MG, Gorin MA, Behr SC. Recent updates and developments in PET imaging of prostate cancer. Abdom Radiol (NY). 2020 Dec; 45 (12):4063-4072
    View PubMed
41. Casal Moura M, Navin PJ, Johnson GB, Hartman TE, Baqir M, Yi ES, Ryu JH. Pulmonary nodules in patients with primary Sjogren's syndrome: Causes, clinico-radiologic features, and outcomes. Respir Med. 2020 Nov - Dec; 174:106200 Epub 2020 Oct 22
    View PubMed
42. Johnson GB, Harms HJ, Johnson DR, Jacobson MS. PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker? Semin Nucl Med. 2020 Nov; 50 (6):549-561 Epub 2020 Aug 07
    View PubMed
43. Carr RM, Duma N, McCleary-Wheeler AL, Almada LL, Marks DL, Graham RP, Smyrk TC, Lowe V, Borad MJ, Kim G, Johnson GB, Allred JB, Yin J, Lim VS, Bekaii-Saab T, Ma WW, Erlichman C, Adjei AA, Fernandez-Zapico ME. Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination. Pancreatology. 2020 Sep; 20 (6):1115-1122 Epub 2020 July 14
    View PubMed
44. Koslow M, Bennji SM, Griffith-Richards S, Ahmad K, Johnson GB, Ryu JH, Nathan SD, Allwood BW. A 48-Year-Old South African Woman with Rheumatoid Arthritis and Lung Nodules. Chest. 2020 May; 157 (5):e151-e155
    View PubMed
45. Cox CW, Chung JH, Ackman JB, Berry MF, Carter BW, de Groot PM, Hobbs SB, Johnson GB, Maldonado F, McComb BL, Tong BC, Walker CM, Kanne JP, Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria(R) Occupational Lung Diseases. J Am Coll Radiol. 2020 May; 17 (5S):S188-S197
    View PubMed
46. Christopoulos C, Bois JP, Kemp BJ, Askew JW, Rodriguez-Porcel M, Gibbons RJ, Johnson GB, Chareonthatawee P. Comparison of Maximal Hyperemic Myocardial Blood Flow Response between regadenoson and adenosine Nuclear Medicine and Biomedical Imaging. 2020.
    
47. Friedman SN, Mahmood M, Geske JR, Sohail MR, Johnson GB, Stulak JM, Kendi AT. Positron emission tomography objective parameters for assessment of left ventricular assist device infection using (18)F-FDG PET/CT. Am J Nucl Med Mol Imaging. 2020; 10 (6):301-311 Epub 2020 Dec 15
    View PubMed
48. Murphy BL, Woodwick AR, Murphy KM, Chandler KJ, Johnson GB, Hunt CH, Peller P, Jakub JW, Homb AC. (99m)Tc-Tilmanocept Versus (99m)Tc-Sulfur Colloid in Lymphoscintigraphy: Sentinel Lymph Node Identification and Patient-Reported Pain. J Nucl Med Technol. 2019 Dec; 47 (4):300-304 Epub 2019 Apr 24
    View PubMed
49. Lee C, Colletti PM, Chung JH, Ackman JB, Berry MF, Carter BW, de Groot PM, Hobbs SB, Johnson GB, Maldonado F, McComb BL, Tong BC, Walker CM, Kanne JP, Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria(R) Acute Respiratory Illness in Immunocompromised Patients. J Am Coll Radiol. 2019 Nov; 16 (11S):S331-S339
    View PubMed
50. Clark MS, Packard AT, Johnson DR, Johnson GB. Pitfalls of a Mixed Metabolic Response at PET/CT. Radiographics. 2019 Sep-Oct; 39 (5):1461-1475 Epub 2019 Aug 09
    View PubMed
51. Koslow. M, Bennji S, Grifftiths-Richards S, Ahmad K, Johnson G, Ryu J, Nathan S, Allwood B. The Mayo clinic Rheumatoid Lung Nodule Score is Tested in South Africa: Lessons from a Telemedicine Trans-Atlantic Multi-Disciplinary Discussion Journal of Telemedicine and Telecare. 2019.
    
52. Panda A, Garg I, Johnson GB, Truty MJ, Halfdanarson TR, Goenka AH. Molecular radionuclide imaging of pancreatic neoplasms. Lancet Gastroenterol Hepatol. 2019 Jul; 4 (7):559-570
    View PubMed
53. Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, Chareonthaitawee P, Friedman PA, Sohail MR. Role of (18)F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2019 Jun; 26 (3):958-970 Epub 2017 Sept 14
    View PubMed
54. Henry TS, Donnelly EF, Boiselle PM, Crabtree TD, Iannettoni MD, Johnson GB, Kazerooni EA, Laroia AT, Maldonado F, Olsen KM, Restrepo CS, Shim K, Sirajuddin A, Wu CC, Kanne JP, Expert Panel on Thoracic Imaging:. ACR Appropriateness Criteria((R)) Rib Fractures. J Am Coll Radiol. 2019 May; 16 (5S):S227-S234
    View PubMed
55. Christopoulos G, Bois JB, Kemp BJ, Askew JW, Rodriguez-Porcel M, Johnson GB. Comparison of maximal hyperemic myocardial blood flow response between regadenoson and adenosine: A quantitative positron emission tomography 13N-ammonia study Nucl Med Biomed Imaging. 2019; 4:1-6.
    
56. Koslow M, Young JR, Yi ES, Baqir M, Decker PA, Johnson GB, Ryu JH. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. Eur Radiol. 2019 Apr; 29 (4):1684-1692 Epub 2018 Oct 04
    View PubMed
57. Welch BT, Packard AT, Atwell TD, Johnson GB, Lowe VJ, Karnes RJ, Mynderse LA, Gunderson TM, Park SS, Stish BJ, Evans JD, Kwon ED, Davis BJ, Nathan MA. Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical Implications. Adv Radiat Oncol. 2019 Jan-Mar; 4 (1):79-89 Epub 2018 Sept 05
    View PubMed
58. Yang M, Covington MF, Nguyen BD, Johnson GB, Mesa RA, Roarke MC. (99m)Tc-Sulfur Colloid Bone Marrow Scintigraphy in Diagnosis of Diffuse Pulmonary Extramedullary Hematopoiesis Secondary to Myelofibrosis. J Nucl Med Technol. 2018 Dec; 46 (4):368-372 Epub 2018 June 08
    View PubMed
59. Donnelly EF, Kazerooni EA, Lee E, Henry TS, Boiselle PM, Crabtree TD, Iannettoni MD, Johnson GB, Laroia AT, Maldonado F, Olsen KM, Shim K, Sirajuddin A, Wu CC, Kanne JP, Expert Panel on Thoracic Imaging:. ACR Appropriateness Criteria((R)) Lung Cancer Screening. J Am Coll Radiol. 2018 Nov; 15 (11S):S341-S346
    View PubMed
60. Johnson GB. Hepatic Infectious and inflammatory conditions: Role of 18F-FDG PET imaging with multimodality correlation and implications for management J Nuc Med. 2018; 59(Supplement 1):1160.
    
61. Broski SM, Goenka AH, Kemp BJ, Johnson GB. Clinical PET/MRI: 2018 Update. AJR Am J Roentgenol. 2018 Aug; 211 (2):295-313 Epub 2018 June 27
    View PubMed
62. Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. (18)F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker. J Nucl Med. 2018 May; 59 (5):774-779 Epub 2017 Nov 02
    View PubMed
63. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of recurrence sites following post-prostatectomy treatment for prostate cancer using c-11-choline positron emission tomography and multiparametric pelvic magnetic resonance imaging Journal Of Urology. 2018 Mar; 199 (3):726-33
    
64. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using (11)C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging. J Urol. 2018 Mar; 199 (3):726-733 Epub 2017 Sept 12
    View PubMed
65. Parvinian A, Martin-Macintosh EL, Goenka AH, Durski JM, Mullan BP, Kemp BJ, Johnson GB. (11)C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas. AJR Am J Roentgenol. 2018 Feb; 210 (2):418-422 Epub 2017 Nov 15
    View PubMed
66. Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M. Hydroxychloroquine-Mediated Cardiotoxicity With a False-Positive 99mTechnetium-Labeled Pyrophosphate Scan for Transthyretin-Related Cardiac Amyloidosis. Circ Cardiovasc Imaging. 2018 Jan; 11(1).
    View PubMed
67. Johnson DR, Hunt CH, Nathan MA, Parisi JE, Boeve BF, Murray ME, Knopman DS, Jack CR Jr, Petersen RC, Lowe VJ, Johnson GB. Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors. J Neurooncol. 2018 Jan; 136 (2):373-378 Epub 2017 Nov 08
    View PubMed
68. Subramaniam RM, Janowitz WR, Johnson GB, Lodge MA, Parisi MT, Ferguson MR, Hellinger JC, Gladish GW, Gupta NK. ACR-SPR-STR Practice Parameter for the Performance of Cardiac Positron Emission Tomography - Computed Tomography (PET/CT) Imaging. Clin Nucl Med. 2017 Dec; 42 (12):918-927
    View PubMed
69. Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, Hope TA. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017 Nov; 46 (5):1247-1262 Epub 2017 Mar 30
    View PubMed
70. Broski SM, Johnson GB, Goenka AH. Gastrointestinal: Multiparametric hybrid 18-FDG PET/MRI evaluation of gastric adenocarcinoma. J Gastroenterol Hepatol. 2017 Jun; 32 (6):1132
    View PubMed
71. Venkatesh SK, Hennedige T, Johnson GB, Hough DM, Fletcher JG. Imaging patterns and focal lesions in fatty liver: a pictorial review. Abdom Radiol (NY). 2017 May; 42 (5):1374-1392
    View PubMed
72. Ravenel JG, Chung JH, Ackman JB, de Groot PM, Johnson GB, Jokerst C, Maldonado F, McComb BL, Steiner RM, Mohammed TL, Expert Panel on Thoracic Imaging:. ACR Appropriateness Criteria((R)) Imaging of Possible Tuberculosis. J Am Coll Radiol. 2017 May; 14 (5S):S160-S165
    View PubMed
73. Sirajuddin A, Donnelly EF, Crabtree TP, Henry TS, Iannettoni MD, Johnson GB, Kazerooni EA, Maldonado F, Olsen KM, Wu CC, Mohammed TL, Kanne JP, Expert Panel on Thoracic Imaging:. ACR Appropriateness Criteria((R)) Suspected Pulmonary Hypertension. J Am Coll Radiol. 2017 May; 14 (5S):S350-S361
    View PubMed
74. Leung N, Ramirez-Alvarado M, Nasr SH, Kemp BJ, Johnson GB. Detection of ALECT2 amyloidosis by positron emission tomography-computed tomography imaging with florbetapir. Br J Haematol. 2017 Apr; 177 (1):12 Epub 2017 Jan 20
    View PubMed
75. Yanagisawa R, Fetterly KA, Johnson GB, Foley TA, Williamson EE, Gulati R, Sandhu GS, Frantz RP. Integrated Use of Perfusion SPECT/CTA Fusion Imaging and Pulmonary Balloon Angioplasty for Chronic Pulmonary Thromboembolism. JACC Cardiovasc Interv. 2017 Mar 13; 10 (5):532-534 Epub 2017 Feb 15
    View PubMed
76. Johnson GB, Aubry MC, Yi ES, Koo CW, Jenkins SM, Garces YI, Marks RS, Cassivi SD, Roden AC. Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors. J Thorac Oncol. 2017 Feb; 12 (2):354-367 Epub 2016 Sept 22
    View PubMed
77. Nagelschneider AA, Broski SM, Holland WP, Midthun DE, Sykes AM, Lowe VJ, Peller PJ, Johnson GB. The flip-flop fungus sign: an FDG PET/CT sign of benignity. Am J Nucl Med Mol Imaging. 2017; 7 (5):212-217 Epub 2017 Nov 01
    View PubMed
78. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol. 2016 Nov 1; 1 (8):880-889
    View PubMed
79. Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ. Multimodality Imaging of Neurodegenerative Processes: Part 1, The Basics and Common Dementias. AJR Am J Roentgenol. 2016 Oct; 207 (4):871-882 Epub 2016 Aug 09
    View PubMed
80. Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ. Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias. AJR Am J Roentgenol. 2016 Oct; 207 (4):883-895 Epub 2016 Aug 09
    View PubMed
81. Haddad MM, Merrell KW, Hallemeier CL, Johnson GB, Mounajjed T, Olivier KR, Fidler JL, Venkatesh SK. Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. Abdom Radiol (NY). 2016 Oct; 41 (10):2061-77
    View PubMed
82. Broski SM, Johnson GB, Howe BM, Nathan MA, Wenger DE, Spinner RJ, Amrami KK. Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors. Skeletal Radiol. 2016 Aug; 45 (8):1097-105 Epub 2016 Apr 26
    View PubMed
83. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133 (24):2404-12 Epub 2016 Apr 22
    View PubMed
84. Lehman VT, Murphy RC, Schenck LA, Carter RE, Johnson GB, Kotsenas AL, Morris JM, Nathan MA, Wald JT, Maus TP. Comparison of facet joint activity on 99mTc-MDP SPECT/CT with facet joint signal change on MRI with fat suppression. Diagn Interv Radiol. 2016 May-Jun; 22 (3):277-83
    View PubMed
85. White ML, Johnson GB, Howe BM, Peller PJ, Broski SM. Spectrum of Benign Articular and Periarticular Findings at FDG PETCT. Radiographics. 2016 May-Jun; 36: (3)824-39.
    View PubMed
86. Broski SM, Spinner RJ, Howe BM, Dispenzieri A, Johnson GB. 18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves. Clin Nucl Med. 2016 Feb; 41 (2):e115-7
    View PubMed
87. Nelson DR, Johnson GB, Cartin-Ceba R, Specks U. Characterization of F-18 Fluorodeoxyglucose PETCT in Granulomatosis with Polyangiitis. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 18; 32: (4)342-52.
    View PubMed
88. Welle CL, Cullen EL, Peller PJ, Lowe VJ, Murphy RC, Johnson GB, Binkovitz LA. (1)(1)C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes. Radiographics. 2016 Jan-Feb; 36 (1):279-92
    View PubMed
89. Bacchus L, Shah RD, Chung JH, Crabtree TP, Heitkamp DE, Iannettoni MD, Johnson GB, Jokerst C, McComb BL, Saleh AG, Steiner RM, Mohammed TL, Ravenel JG, Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria Review ACR Appropriateness Criteria(R) Occupational Lung Diseases. J Thorac Imaging. 2016 Jan; 31: (1)W1-3.
    View PubMed
90. DeGrado TR, Kemp BJ, Pandey MK, Jiang H, Gunderson TM, Linscheid LR, Woodwick AR, McConnell DM, Fletcher JG, Johnson GB, Petersen RC, Knopman DS, Lowe VJ. First PET Imaging Studies With 63Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease. Mol Imaging. 2016; 15 Epub 2016 Dec 09
    View PubMed
91. Wells ML, Venkatesh SK, Chandan VS, Fidler JL, Fletcher JG, Johnson GB, Hough DM, Roberts LR. Biphenotypic hepatic tumors: imaging findings and review of literature. Abdom Imaging. 2015 Oct; 40 (7):2293-305
    View PubMed
92. Del Valle Somiedo Gutierrez M, Villasboas Bisneto JC, Lee CU, Johnson GB, Shen RK, Maldonado F. Pseudomyxoma pleuri. A rare manifestation of an uncommon disease. Am J Respir Crit Care Med. 2015 Jun 1; 191(11):1334-5.
    View PubMed
93. Heitkamp DE, Albin MM, Chung JH, Crabtree TP, Iannettoni MD, Johnson GB, Jokerst C, McComb BL, Saleh AG, Shah RD, Steiner RM, Mohammed TL, Ravenel JG, Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria(R) acute respiratory illness in immunocompromised patients. J Thorac Imaging. 2015 May; 30 (3):W2-5
    View PubMed
94. Brinjikji W, Boland Froemming JM, Holland WP, Peikert T, Johnson GB. Unexpectedly fludeoxyglucose (18F) avid well-differentiated adenocarcinoma of the lung. J Thorac Oncol. 2015 Apr; 10 (4):719-20
    View PubMed
95. Bartholmai BJ, Koo CW, Johnson GB, White DB, Raghunath SM, Rajagopalan S, Moynagh MR, Lindell RM, Hartman TE. Pulmonary nodule characterization, including computer analysis and quantitative features. J Thorac Imaging. 2015 Mar; 30 (2):139-56
    View PubMed
96. Platt JL, Wrenshall LE, Johnson GB, Cascalho M. Heparan sulfate proteoglycan metabolism and the fate of grafted tissues. Adv Exp Med Biol. 2015; 865:123-40.
    View PubMed
97. Johnson GB, Peller PJ, Kemp BJ, Ryu JH. Future of thoracic PET scanning. Chest. 2015 Jan; 147: (1)25-30.
    View PubMed
98. Dvorak LA, Vassallo R, Kirmani S, Johnson G, Hartman TE, Tazelaar HD, Leslie KO, Colby TV, Cockcroft DW, Churg AM, Yi ES. Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases. Hum Pathol. 2015 Jan; 46: (1)147-52.
    View PubMed
99. Leung N, Grogan M, Johnson GB, Klecka ME, Dispenzeiri A. Pulmonary masses in a patient with dyspnea: Apply Occam's razor or Hickam's dictum? Am J Hematol. 2015; 90(5):462-5.
    View PubMed
100. Crush AB, Howe BM, Spinner RJ, Amrami KK, Hunt CH, Johnson GB, Murphy RC, Morreale RF, Peller PJ. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation. Radiographics. 2014 Nov-Dec; 34 (7):1987-2007
     View PubMed
101. Westerly BD, Johnson GB, Maldonado F, Utz JP, Specks U, Peikert T. Targeting B lymphocytes in progressive fibrosing mediastinitis. Am J Respir Crit Care Med 2014 Nov 1; 190 (9):1069-71
     View PubMed
102. Broski SM, Hunt CH, Johnson GB, Morreale RF, Lowe VJ, Peller PJ. Structural and functional imaging in parkinsonian syndromes. Radiographics. 2014 Sep-Oct; 34 (5):1273-92
     View PubMed
103. Sun G, Tian J, Gorospe EC, Johnson GB, Hunt CH, Lutzke LS, Leggett CL, Iyer PG, Wang KK. Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma. J Gastroenterol Hepatol. 2013 Jun; 28(6):975-81.
     View PubMed
104. Howe BM, Johnson GB, Wenger DE. Current concepts in MRI of focal and diffuse malignancy of bone marrow. Semin Musculoskelet Radiol. 2013 Apr; 17(2):137-44. Epub 2013 May 14.
     View PubMed
105. Clapp AJ, Hunt CH, Johnson GB, Peller PJ. Semiquantitative analysis of brain metabolism in patients with paraneoplastic neurologic syndromes. Clin Nucl Med. 2013 Apr; 38: (4)241-7.
     View PubMed
106. McMenomy BP, Kurup AN, Johnson GB, Carter RE, McWilliams RR, Markovic SN, Atwell TD, Schmit GD, Morris JM, Woodrum DA, Weisbrod AJ, Rose PS, Callstrom MR. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol. 2013 Feb; 24: (2)207-13.
     View PubMed
107. Iqbal S, DePew ZS, Kurtin PJ, Sykes AM, Johnson GB, Edell ES, Habermann TM, Maldonado F. Endobronchial ultrasound and lymphoproliferative disorders: a retrospective study. Ann Thorac Surg. 2012 Dec; 94: (6)1830-4.
     View PubMed
108. Gu CN, Hunt CH, Lehman VT, Johnson GB, Diehn FE, Schwartz KM, Eckel LJ. Benign fibrous dysplasia on [(11)C]choline PET: a potential mimicker of disease in patients with biochemical recurrence of prostate cancer. Ann Nucl Med. 2012 Aug; 26(7):599-602. Epub 2012 Jun 07.
     View PubMed
109. Broski SM, Hunt CH, Johnson GB, Subramaniam RM, Peller PJ. The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. J Nucl Med. 2012 Aug; 53: (8)1200-6.
     View PubMed
110. Chandler KJ, Hunt CH, Morreale R, Johnson GB, Peller PJ. Effect of patient age, breast density, and topical anesthetic cream on perceived pain with sentinel lymph node scintigraphy. J Nucl Med Technol. 2012 Mar; 40(1):44-7. Epub 2012 Jan 06.
     View PubMed
111. Johnson GB, Peller PJ, Bahrami A, Subramaniam RM. AJR teaching file: left neck mass evaluated by PET/CT. AJR Am J Roentgenol. 2011 Jun; 196: (6 Suppl)WS78-82.
     View PubMed
112. Kujak JL, Liu PT, Johnson GB, Callstrom MR. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol. 2010 Feb; 39 (2):175-82 Epub 2009 Sept 21
     View PubMed
113. Brunn GJ, Bungum MK, Johnson GB, Platt JL. Conditional signaling by Toll-like receptor 4. FASEB J. 2005 May; 19 (7):872-4 Epub 2005 Feb 28
     View PubMed
114. Johnson GB, Brunn GJ, Samstein B, Platt JL. New insight into the pathogenesis of sepsis and the sepsis syndrome. Surgery. 2005 Apr; 137(4):393-5.
     View PubMed
115. Johnson GB, Riggs BL, Platt JL. A genetic basis for the "Adonis" phenotype of low adiposity and strong bones. FASEB J. 2004 Aug; 18 (11):1282-4 Epub 2004 June 18
     View PubMed
116. Samstein B, Johnson GB, Platt JL. Toll-like receptor-4 and allograft responses. Transplantation. 2004 Feb 15; 77 (3):475-7
     View PubMed
117. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol. 2004 Jan 1; 172 (1):20-4
     View PubMed
118. Johnson GB, Brunn GJ, Tang AH, Platt JL. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol. 2003 Jan; 24 (1):19-24
     View PubMed
119. Johnson GB, Brunn GJ, Platt JL. Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol. 2003; 23 (1-2):15-44
     View PubMed
120. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol. 2002 May 15; 168 (10):5233-9
     View PubMed
121. Platt JL, Johnson GB, Kodaira Y, Wrenshall LE. Tolerance and the microenvironment. Transplantation. 2001 Oct 27; 72(8 Suppl):S23-4.
     View PubMed